Magellan Bioscience Group, Inc.

Country/Region: Russia     State/Province: Saint Petersburg

Main Products: Generic Pharmaceutical Products

Company Introduction
Generic Pharmaceutical CRO manufacturer of cGMP and non-GMP materials (solids, semi-solids, oral solutions, etc.).
Company Overview

Business Type: Wholesaler, Retailer

Year Established: 1997

Employees: 201 - 300 People

Plant Area: 10,000-30,000 square meters

Contact Information

Fax: 1-440-7451300

Business Information

Main Markets: South America 10% Africa 11% Eastern Asia 10% Domestic Market 11% North America 9% Eastern Europe 11% Southern Europe 9% Mid East 10% Northern Europe 9% Oceania 10%

Trade Capacity: FOB, CIP, DAF

Contract Manufacturing: OEM Service Offered Design Service Offered

Nearest Port: Saint Petersburg

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: US$5 Million - US$10 Million

Export Revenue: US$5 Million - US$10 Million

Annual Output: US$10 Million - US$50 Million

Registered Capital: Above US$100 Million

Export Percentage: 21% - 30%

Payment Modes: USD, JPY, CHF

Lead Time: 33 days

Import/Export Mode: LLC (Limited Liability Corp)

Product Showcase
Generic Pharmaceutical Products

CL-Link > Health & Medicines in Russia Health & Medicines in Saint Petersburg Medicines in Russia Medicines in Saint Petersburg Generic Pharmaceuticals in Russia Generic Pharmaceuticals in Saint Petersburg